Possible Support Area on Compass Therapeutics Since its IPO, Compass Therapeutics has been fairly volatile. From it's Covid lows, it had quite a run, gaining over 300% in a fairly short amount of time. There was heavy insider buying and very little short interest. This happened all while the overall market and indices were making the 2022 lo